Today's Insider Trading Highlights — August 08, 2026
📅 Published: August 08, 2026 at 12:01 PM UTC
5 Cluster Buys5 Insider Purchases
On August 08, 2026, we detected 5 new cluster buys including a $15.1M purchase in $ATTO by 2 insiders, and 5 notable insider purchases. Forbion Growth Opportunities Fund III Cooperatief U.A. (10% Owner) bought $34.6M of $BRVE. Data sourced from SEC Form 4 filings analyzed by Average Insider.
⚠️ For information purposes only. This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.
📊 Insider Trading Insights — August 08, 2026
Tracking insider purchases and cluster buys over the past 7 days. Insider buying can indicate confidence in a company's future, while cluster buys (multiple insiders buying around the same time) are particularly noteworthy signals.
🔥 Cluster Buys
$20.17
Current Price
52W: $18.64 – $20.94
$1.00
Fair Value
Participants 2 insiders | Total Shares 888,235 | Total Value $15,099,995 |
Timeframe 0 days | Date Range Aug 06, 2026 – Aug 06, 2026 |
👥 Participant Details
P&L: +18.6% (+$1,864,705) |
P&L: +18.6% (+$951,000) |
📊 Valuation & Analyst Info
Fair Value: $1.00 (-95.1% overvalued vs current price)
P/E Ratio: -15.4
📰 Recent News (Last 7 Days)
$49.31
Current Price
52W: $42.20 – $109.50
$99.21
Fair Value
Participants 2 insiders | Total Shares 189,522 | Total Value $9,158,231 |
Timeframe 2 days | Date Range Aug 03, 2026 – Aug 05, 2026 |
👥 Participant Details
P&L: +2.6% (+$1,297) |
P&L: +2.0% (+$182,087) | ||||
P&L: +1.5% (+$101) |
P&L: +3.6% (+$3,614) |
📊 Valuation & Analyst Info
Fair Value: $99.21 (+101.2% undervalued vs current price)
P/E Ratio: 48.6 (1.0x above Healthcare avg (24.2))
Analyst Consensus: Buy
Price Target: $66.50 (Low: $50.00 | High: $100.00 | Median: $63.50)
$30.00
Current Price
52W: $28.46 – $32.00
Participants 5 insiders | Total Shares 227,498 | Total Value $4,094,964 |
Timeframe 0 days | Date Range Aug 07, 2026 – Aug 07, 2026 |
👥 Participant Details
P&L: +66.7% (+$999,996) |
P&L: +66.7% (+$49,992) | ||||
P&L: +66.7% (+$999,996) |
P&L: +66.7% (+$666,660) | ||||
P&L: +66.7% (+$13,332) |
$20.88
Current Price
52W: $19.63 – $42.23
$88.28
Fair Value
Participants 5 insiders | Total Shares 81,463 | Total Value $1,742,874 |
Timeframe 2 days | Date Range Aug 03, 2026 – Aug 05, 2026 |
👥 Participant Details
P&L: -4.0% ($11,271) |
P&L: -4.0% ($5,517) | ||||
P&L: -0.9% ($950) |
P&L: -2.9% ($5,756) | ||||
P&L: -3.1% ($2,821) |
P&L: -3.1% ($5,764) | ||||
P&L: -2.9% ($6,171) |
P&L: -0.7% ($3,675) |
📊 Valuation & Analyst Info
Fair Value: $88.28 (+322.8% undervalued vs current price)
P/E Ratio: 23.2
Analyst Consensus: Buy
Price Target: $35.00 (Low: $35.00 | High: $35.00 | Median: $35.00)
$45.34
Current Price
52W: $36.61 – $120.05
$258.89
Fair Value
Participants 3 insiders | Total Shares 25,290 | Total Value $1,115,844 |
Timeframe 2 days | Date Range Aug 05, 2026 – Aug 07, 2026 |
👥 Participant Details
P&L: +3.0% (+$6,700) |
P&L: +2.0% (+$8,900) | ||||
P&L: +3.5% (+$15,150) |
P&L: +0.4% (+$55) |
📊 Valuation & Analyst Info
Fair Value: $258.89 (+471.0% undervalued vs current price)
P/E Ratio: 36.7
Analyst Consensus: Buy
Price Target: $69.00 (Low: $47.00 | High: $110.00 | Median: $50.00)
📰 Recent News (Last 7 Days)
💰 Individual Insider Buys
$30.00
Current Price
52W: $28.46 – $32.00
Transaction Date Aug 07, 2026 | Shares 1,920,000 | Purchase Price $18.00 |
Purchase Value $34,560,000 |
P&L: +66.7% (+$23,040,000)
$30.00
Current Price
52W: $28.46 – $32.00
Transaction Date Aug 07, 2026 | Shares 1,680,000 | Purchase Price $18.00 |
Purchase Value $30,240,000 |
P&L: +66.7% (+$20,160,000)
Transaction Date Aug 06, 2026 | Shares 404,694 | Purchase Price $24.71 |
Purchase Value $10,000,000 |
$20.17
Current Price
52W: $18.64 – $20.94
$1.00
Fair Value
Transaction Date Aug 06, 2026 | Shares 400,000 | Purchase Price $17.00 |
Purchase Value $6,800,000 |
P&L: +18.6% (+$1,268,000)
📊 Valuation & Analyst Info
Fair Value: $1.00 (-95.1% overvalued vs current price)
P/E Ratio: -15.4
📰 Recent News (Last 7 Days)
$20.17
Current Price
52W: $18.64 – $20.94
$1.00
Fair Value
Transaction Date Aug 06, 2026 | Shares 300,000 | Purchase Price $17.00 |
Purchase Value $5,100,000 |
P&L: +18.6% (+$951,000)
📊 Valuation & Analyst Info
Fair Value: $1.00 (-95.1% overvalued vs current price)
P/E Ratio: -15.4
📰 Recent News (Last 7 Days)
⚠️ Important Disclaimers
Investment Disclaimer: This content is for informational purposes only and should not be considered investment advice.
Data Accuracy: All information is sourced from SEC filings and third-party data providers. Errors or omissions may occur.
Market Risks: Past insider buying activity does not guarantee future performance.
Professional Advice: Consult with qualified financial professionals before making any investment decisions.
📚 Deep Dive Resources
Data sourced from SEC filings. This is for informational purposes only.
Want to receive these newsletters in your inbox? Sign up here